S

Sleep Therapy and Research Center | Medical Center Drive Office

Research site

Location

5290 Medical Drive, San Antonio, Texas, United States of America

Site insights

Top conditions

Top treatments

TAK-861

E2086

Atomoxetine

HBS-301

ADX-N05

Aroxybutynin

Armodafinil

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

4 of 17 total trials

Locations recently updated

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

This is a Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled clinical study to assess the efficacy and safety of HBS-...

Enrolling

Idiopathic Hypersomnia

Drug: HBS-301 tablet

Drug: Placebo

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

The main aim is to evaluate the safety and tolerability of TAK-861 in participants with type 1 narcolepsy, who were exposed to previously tested dose...

Enrolling

Narcolepsy Type 1

Drug: TAK-861

A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy

The primary purpose of this study is to evaluate the optimal doses of E2086 compared to placebo in participants with narcolepsy for reduction of exce...

Enrolling

Narcolepsy

Drug: E2086

Drug: Placebo

Continuation Protocol for Obstructive Sleep Apnea (OSA)

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only

OSA

Drug: Aroxybutynin and Atomoxetine